Clinical Trials for Gannex Pharma

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Gannex Pharma

Clinical Trials (2)

NCT05462353
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH
PHASE2Active, not recruiting
183 participants
Started: Sep 30, 2022 · Completed: Jun 10, 2025
2 conditions1 sponsor1 location
NCT05287399
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors
PHASE1Recruiting
16 participants
Started: Aug 2, 2022 · Completed: Dec 20, 2024
1 condition2 sponsors4 locations